These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24092875)

  • 21. Impact of change in high-density lipoprotein cholesterol from baseline on risk for major cardiovascular events.
    Laitinen DL; Manthena S
    Adv Ther; 2010 Apr; 27(4):233-44. PubMed ID: 20437214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dalcetrapib in patients with a recent acute coronary syndrome.
    Schwartz GG; Olsson AG; Abt M; Ballantyne CM; Barter PJ; Brumm J; Chaitman BR; Holme IM; Kallend D; Leiter LA; Leitersdorf E; McMurray JJ; Mundl H; Nicholls SJ; Shah PK; Tardif JC; Wright RS;
    N Engl J Med; 2012 Nov; 367(22):2089-99. PubMed ID: 23126252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Amarenco P; Goldstein LB; Callahan A; Sillesen H; Hennerici MG; O'Neill BJ; Rudolph AE; Simunovic L; Zivin JA; Welch KM;
    Atherosclerosis; 2009 Jun; 204(2):515-20. PubMed ID: 18962621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of serum lipid level change on 10-year coronary heart risk distribution estimated by means of seven different coronary risk scores during one-year treatment.
    Kojić NE; Derić M; Dejanović J
    Med Pregl; 2014; 67(7-8):208-15. PubMed ID: 25151760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosis.
    Sung KC; Wild SH; Byrne CD
    Atherosclerosis; 2013 Dec; 231(2):181-6. PubMed ID: 24267222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations.
    Primdahl J; Clausen J; Hørslev-Petersen K
    Ann Rheum Dis; 2013 Nov; 72(11):1771-6. PubMed ID: 23852694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
    Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH
    Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality.
    Silbernagel G; Schöttker B; Appelbaum S; Scharnagl H; Kleber ME; Grammer TB; Ritsch A; Mons U; Holleczek B; Goliasch G; Niessner A; Boehm BO; Schnabel RB; Brenner H; Blankenberg S; Landmesser U; März W
    Eur Heart J; 2013 Dec; 34(46):3563-71. PubMed ID: 24014391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
    Bruckert E; Baccara-Dinet M; Eschwege E
    Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between The Family Nutrition and Physical Activity Screening Tool and cardiovascular disease risk factors in 10-year old children.
    Yee KE; Eisenmann JC; Carlson JJ; Pfeiffer KA
    Int J Pediatr Obes; 2011 Aug; 6(3-4):314-20. PubMed ID: 21728777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New european guidelines for dyslipidemia].
    Riesen WF; Virgini V; Vogt B; Rodondi N
    Rev Med Suisse; 2012 Mar; 8(331):525-6, 528-30. PubMed ID: 22471115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
    Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
    Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The associations between current recommendation for physical activity and cardiovascular risks associated with obesity.
    Akbartabartoori M; Lean ME; Hankey CR
    Eur J Clin Nutr; 2008 Jan; 62(1):1-9. PubMed ID: 17342166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
    Hadaegh F; Harati H; Ghanbarian A; Azizi F
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
    Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
    Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.
    Sritara P; Patoomanunt P; Woodward M; Narksawat K; Tulyadachanon S; Ratanachaiwong W; Sritara C; Barzi F; Yamwong S; Tanomsup S
    Angiology; 2007 Dec-2008 Jan; 58(6):757-63. PubMed ID: 18216384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on the body mass index and waist circumference of aged with clustering of other cardiovascular risk factors].
    Zhang FM; Xu HJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jan; 41(1):33-7. PubMed ID: 17484208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk prediction of incident coronary heart disease in The Netherlands: re-estimation and improvement of the SCORE risk function.
    Merry AH; Boer JM; Schouten LJ; Ambergen T; Steyerberg EW; Feskens EJ; Verschuren WM; Gorgels AP; van den Brandt PA
    Eur J Prev Cardiol; 2012 Aug; 19(4):840-8. PubMed ID: 21551214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
    Koro CE; Bowlin SJ; Stump TE; Sprecher DL; Tierney WM
    Am Heart J; 2006 Mar; 151(3):755.e1-755.e6. PubMed ID: 16504648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.